Darbre P D, King R J
Department of Cellular Endocrinology, Imperial Cancer Research Fund, London, England.
Cell. 1987 Nov 20;51(4):521-8. doi: 10.1016/0092-8674(87)90121-8.
A major problem in treatment of cancers arising in steroid-sensitive cells is their inevitable progression to a steroid-insensitive state; current therapies are based on the assumption that hormone insensitivity is associated with loss of receptor. We demonstrate for the first time that breast tumor cells can progress to steroid insensitivity in spite of functional steroid receptors. Transfection of the steroid-inducible LTR-C3 gene into unresponsive S115 mouse mammary tumor cells results in full inducibility of that gene with both androgen and glucocorticoid. Thus, although all known endogenous inducible parameters are lost, the steroid sensitivity of a transfected exogenous gene demonstrates that the machinery for steroid responsiveness is still fully functional. Furthermore, these transfected genes retain steroid sensitivity only while steroid is present; on prolonged withdrawal of steroid, they lose responsiveness, implying an epigenetic mechanism is involved.
治疗源自类固醇敏感细胞的癌症时,一个主要问题是它们不可避免地会发展为类固醇不敏感状态;目前的治疗方法基于这样一种假设,即激素不敏感与受体丧失有关。我们首次证明,尽管存在功能性类固醇受体,乳腺肿瘤细胞仍可发展为类固醇不敏感。将类固醇诱导型LTR-C3基因转染到无反应的S115小鼠乳腺肿瘤细胞中,可使该基因在雄激素和糖皮质激素作用下完全被诱导。因此,尽管所有已知的内源性诱导参数都丧失了,但转染的外源基因的类固醇敏感性表明,类固醇反应机制仍然完全功能正常。此外,这些转染基因仅在有类固醇存在时才保持类固醇敏感性;长时间撤除类固醇后,它们会失去反应性,这意味着涉及一种表观遗传机制。